Human diseases implicating defects in CD46-mediated signaling (reviewed in [17]) are multiple sclerosis, rheumatoid arthritis, asthma, IPEX-like syndrome, and primary C3 deficiency. This evidence concerns the gene CD46 and hyperinsulinemic hypoglycemia, familial, 4.